By As of September 2026, the Roundup lawsuit remains unresolved. A proposed $7.25 billion class settlement has received preliminary approval, but it has not received final approval. A June 2026 U.S. Supreme Court ruling also narrowed one legal theory used in Roundup cases. A final approval hearing is scheduled for September 14, 2026, in Missouri state court.
The litigation itself is not over. Thousands of cases remain active in federal and state courts, and no claimant has been promised a specific payout. The key issues now are whether the proposed settlement receives final approval, how the Supreme Court ruling affects individual cases, and what happens to claims outside the settlement.
What Is the Roundup Lawsuit?
The term “Roundup lawsuit” refers to product liability cases filed against Monsanto, the manufacturer of Roundup weedkiller, and its parent company Bayer, which acquired Monsanto in 2018. Plaintiffs allege that long-term exposure to Roundup, whose active ingredient is glyphosate, contributed to non-Hodgkin lymphoma, a type of blood cancer.
Lawsuits generally allege that Monsanto knew or should have known about a potential cancer risk associated with glyphosate and failed to provide an adequate warning. Some cases also raise design defect, negligence, or misrepresentation claims. Bayer disputes these allegations and maintains that Roundup is safe when used as directed, pointing to regulatory reviews by the U.S. Environmental Protection Agency.
The litigation includes individual lawsuits as well as a proposed class settlement intended to resolve a large share of current and future claims.
What Did the Supreme Court Decide in 2026?
On June 25, 2026, the U.S. Supreme Court ruled 7-2 in Monsanto Co. v. Durnell that federal pesticide law preempts state-law failure-to-warn claims against Roundup. The Court reasoned that because the EPA approved Roundup’s label without requiring a cancer warning, the Federal Insecticide, Fungicide, and Rodenticide Act prevents state lawsuits seeking a different or additional warning.
The case involved a Missouri jury verdict of more than $1 million for plaintiff John Durnell based on a failure-to-warn theory. The Supreme Court reversed the judgment and sent the case back to the lower courts.
The ruling does not resolve every Roundup claim. Plaintiffs and settlement objectors have argued that it addresses warning-label claims rather than separate allegations involving defective design, negligence, or certain misrepresentation theories. Judge Vince Chhabria, who oversees the federal Roundup multidistrict litigation (MDL 2741) in California, has indicated that the decision does not automatically end every pending case and that remaining legal questions require further analysis.
Status of the Proposed $7.25 Billion Settlement
In February 2026, Bayer’s Monsanto unit proposed a nationwide class settlement worth up to $7.25 billion for current and future non-Hodgkin lymphoma claims tied to Roundup. The proposal, filed in Missouri state court in King v. Monsanto, would provide payments over 17 to 21 years under a declining annual funding schedule. It is designed to cover roughly 65,000 pending claims along with qualifying future claims.
A Missouri circuit judge granted preliminary approval on March 4, 2026. Preliminary approval does not mean the settlement is final. It allows the process to move forward, including notice to class members, an opt-out period, objections, and a fairness hearing.
The settlement has faced significant opposition. Law firms representing more than 20,000 plaintiffs objected that the agreement undervalues claims. There were also disputes over moving the case into federal court, but the matter was returned to Missouri state court. The fairness hearing was postponed twice and is now scheduled for September 14, 2026.
As of this writing, the $7.25 billion settlement remains proposed and preliminarily approved only. Bayer retains the right to withdraw if participation falls below its target, and objections remain pending. Individual cases in federal court and claims pursued outside the class settlement continue separately.
How Much Could a Claimant Receive?
There is no single Roundup settlement amount. If the proposed settlement is finalized, compensation is expected to vary according to a compensation grid and each claimant’s circumstances.
Public estimates connected to the proposed framework suggest payments could range from roughly $6,000 to $165,000, with possible additional amounts in qualifying situations. These figures are estimates, not guaranteed awards. The final compensation formula, eligibility rules, and payment tiers depend on final court approval and any subsequent appeals.
Factors expected to affect a claim include:
• The duration and intensity of Roundup exposure, including occupational or residential use
• The type and severity of the cancer diagnosis and supporting medical records
• The claimant’s age and health history
• Documentation showing product use, such as purchase or employment records
• Whether the claim is handled through the class settlement or as an individual lawsuit
Settlement estimates should also be distinguished from jury verdicts. Some individual Roundup trials produced much larger awards, including verdicts of $2 billion, $289 million, and $80 million, although many were later reduced on appeal. Those trial outcomes are not representative of a typical payment under the proposed settlement.
Is the Roundup Lawsuit Legitimate?
Yes. The underlying Roundup litigation is a real, court-documented legal matter. It includes the federal MDL 2741, the Missouri class settlement case, and the 2026 Supreme Court case Monsanto Co. v. Durnell.
However, legitimate litigation can also attract misleading advertising and scams. A genuine claims process, if the settlement receives final approval, would be administered through an official, court-appointed claims administrator. A law firm advertisement may be legitimate, but an advertisement alone does not establish that a person qualifies for compensation.
Be cautious of unsolicited messages promising guaranteed settlement money, demands for upfront payment to secure a payout, or pressure to act immediately. Eligibility is not automatic and generally depends on meeting specific requirements, including a documented diagnosis and evidence of Roundup exposure.
A Brief History of the Litigation
The modern Roundup litigation traces back to 2015, when the World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans.” Other regulators, including the EPA, have reached different conclusions about glyphosate’s cancer risk.
In October 2016, the Judicial Panel on Multidistrict Litigation consolidated federal Roundup cases into MDL 2741 in the U.S. District Court for the Northern District of California. A major trial verdict followed in 2018 in favor of a California school groundskeeper who developed non-Hodgkin lymphoma. Bayer completed its $63 billion acquisition of Monsanto that same year.
Large verdicts followed in 2019 and 2020. In June 2020, Bayer agreed to pay roughly $10.9 billion to resolve about 100,000 existing claims, but that agreement did not cover future claims from people who had not yet been diagnosed. In 2021, Judge Chhabria rejected a separate proposal for future claims. New filings continued, leading to the current settlement proposal and the Supreme Court’s 2026 ruling.
Individual Lawsuit vs. Class Settlement
An individual lawsuit is litigated according to the claimant’s specific facts. It may proceed to trial or settle separately with Bayer. This route can potentially produce a larger recovery, but it can also take longer and involves greater uncertainty.
A class settlement uses a common framework with standardized eligibility requirements and a compensation grid. It can provide greater predictability than an individual trial, but an eligible claimant’s recovery is determined by the settlement terms. Some plaintiffs may opt out to preserve an individual claim, while others may remain in the class unless they take steps to exclude themselves.
Because the proposed settlement has not received final approval, the legal position of each claimant can differ depending on prior filings, opt-out status, diagnosis, exposure history, and applicable deadlines.
What Should You Do If You Think You Have a Claim?
If you believe you may have a Roundup claim, gather documentation before making decisions about a settlement or lawsuit. Useful records may include:
• Medical records confirming non-Hodgkin lymphoma or a related diagnosis
• Evidence of Roundup exposure, such as purchase receipts, employment records, or dates and locations of use
• Information about when the diagnosis occurred
Consider consulting a licensed attorney for a case evaluation before signing a settlement, release, or representation agreement. Ask whether the attorney would recommend an individual lawsuit, participation in the class settlement, or waiting for further developments.
Statutes of limitations vary by state and can depend on factors such as the date of diagnosis, so timing can matter.
What Happens Next?
The immediate milestone is the September 14, 2026 fairness hearing in Missouri state court. The judge could approve the settlement, approve it with changes, deny it, or delay a decision. Even if approved, appeals could extend the timeline.
Separately, the federal MDL continues to handle cases outside the state-court settlement track. The Supreme Court’s preemption ruling is expected to affect failure-to-warn claims, while other theories such as design defect and negligence may require separate analysis.
For now, the Roundup litigation remains active. The proposed $7.25 billion settlement is not yet final, individual cases continue, and compensation figures remain estimates rather than guaranteed payouts.
Frequently Asked Questions
What is the Roundup lawsuit?
It is the collective term for thousands of product liability cases against Monsanto and Bayer alleging that Roundup exposure contributed to non-Hodgkin lymphoma, along with a proposed settlement intended to resolve many claims.
Is the Roundup lawsuit legitimate?
Yes. The litigation is documented through federal and state court proceedings and includes the 2026 Supreme Court ruling. However, not every advertisement or message offering settlement money is trustworthy.
How much is the Roundup settlement per person?
Under the proposed framework, public estimates range from roughly $6,000 to $165,000 depending on claim-specific factors. These amounts are not guaranteed and the settlement is not yet finally approved.
Is there a Roundup settlement in 2026?
There is a proposed $7.25 billion settlement that received preliminary approval in March 2026. Final approval is still pending.
Can anyone file a Roundup lawsuit?
Not necessarily. A viable claim generally requires a qualifying diagnosis, meaningful Roundup exposure, supporting evidence, and compliance with applicable legal requirements and deadlines.
Conclusion
The Roundup lawsuit is an active and well-documented legal matter, but it is not a completed settlement with guaranteed payouts. As of September 2026, the Supreme Court has narrowed one legal theory, while the proposed $7.25 billion settlement remains awaiting final approval in Missouri.
Individual lawsuits continue in parallel, and potential compensation varies widely by claim. Anyone researching a possible Roundup claim should rely on verified court information and a qualified legal evaluation rather than advertisements or promises of automatic settlement money.
